ASCAPE

Artificial intelligence Supporting CAncer Patients across Europe

The project objective is to take advantage of the advances in Big Data, Artificial Intelligence and Machine Learning to support cancer patients’ quality of life and health status. To this end, it will create an open AI infrastructure enabling health stakeholders (hospitals, research institutions, companies, etc.) to deploy and execute AI algorithms locally on their private data. Any new knowledge produced by this process can be shared while the medical data still remains private. The services to be designed, piloted and deployed include intelligent interventions for physiological and psychological support, improved patient and family counselling and guidance, early diagnosis and forecasts of ill-health, identification of disease trajectories and relapse, improved health literacy etc. ASCAPE focuses the training of the AI in two types of cancer, breast and prostate.

Duration: Jan 1, 2020 - Dec 31, 2022
Partners: Gioumpitek Meleti Schediasmos Ylopoiisi Kai Polisi Ergon Pliroforikis Etaireia Periorismenis
Efthynis, Greece
ATOS Spain
Siemens SRL, Romania
INTRASOFT International, Luxembourg
Panepistimio Patron, Greece
Idryma Technologias Kai Erevnas, Greece
SPHYNX Technology Solutions AG, Switzerland
University of Novi Sad Faculty of Sciences, Serbia
CareAcross, UK
Ethniko Kai Kapodistriako Panepistimio Athinon, Greece
Fundacio Clinic Per A La Recerca Biomedica, Spain
Orebro Lans Landsting, Sweden
Arthur's Legal BV, The Netherlands
Fundacion Isys Internet Salud y Sociedad, Spain
Research area: Smart Living  
Grant number: 875351
Funding:
© DFKI GmbH
last updated 15/04/2020
to top